By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login

Apollomics, Inc. (APLMW)

NASDAQ Currency in USD
$0.02
$0.00
+1.29%
Last Update: 11 Sept 2025, 20:00
$3.76M
Market Cap
0.00
P/E Ratio (TTM)
Forward Dividend Yield
$0.02 - $0.03
52 Week Range

APLMW Stock Price Chart

Explore Apollomics, Inc. interactive price chart. Choose custom timeframes to analyze APLMW price movements and trends.

APLMW Company Profile

Discover essential business fundamentals and corporate details for Apollomics, Inc. (APLMW) to support your stock research and investment decisions.

Sector

Financial Services

Industry

Financial - Conglomerates

IPO Date

30 Mar 2023

Employees

13.00

CEO

Guo-Liang Yu

Description

Apollomics, Inc. is a clinical-stage biotechnology company, which engages in the discovery and development of oncology therapies to address unmet medical needs. The company was founded by Liang Yu Guo and Sanjeev Redkar in 2015 and is headquartered in Foster City, CA.

APLMW Financial Timeline

Browse a chronological timeline of Apollomics, Inc. corporate events including earnings releases, dividend announcements, and stock splits.

No results found.

APLMW Stock Performance

Access detailed APLMW performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run